- Home
- Research
- Endocannabinoid
- Human Stem Cell-Derived Neurospheroids and a Multi-Assay Strategy Provide Brain Cytotoxicity New Insights from ADB-FUBIATA Exposure.
Lab-grown brain models reveal lasting damage from a synthetic cannabinoid
Human Stem Cell-Derived Neurospheroids and a Multi-Assay Strategy Provide Brain Cytotoxicity New Insights from ADB-FUBIATA Exposure.
AI Summary
Researchers used 3D human stem-cell-derived neuronal spheroids—lab-grown models designed to better mimic the brain’s cellular environment—to study the synthetic cannabinoid ADB-FUBIATA. A single exposure reduced cell viability at 2000 nM after 24 hours and at ≥800 nM after 48 hours. It also weakened spheroid structure, altered cell-adhesion and neuronal markers, reduced collagen fibre content, and increased the space between cells. The CB1 receptor and NF-κB p50 were not modified under the tested conditions.
Repeated exposure produced broader, concentration-dependent damage by day 10, including cell mortality at ≥200 nM, loss of spheroid compactness at ≥50 nM, and disaggregation or shrinkage at higher concentrations. These findings provide mechanistic evidence that persistent exposure to some synthetic cannabinoids can harm brain-like cellular structures. Because the study used a laboratory model rather than people, it does not establish clinical effects or safe human exposure levels—but it supports further toxicological evaluation and cautions against assuming that synthetic cannabinoids have the same safety profile as cannabis or THC.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Endocannabinoid research papers you might find interesting.
CBD prevented stress-related fear-extinction deficits in male rats
Cell imaging maps MAGL probe engagement, not the enzyme itself
Rodent research links enrichment and isolation to altered endocannabinoid…
Explore More Research
Stay informed about the latest cannabis science.